scispace - formally typeset
M

Marco Bellinzoni

Researcher at University of Paris

Publications -  60
Citations -  2028

Marco Bellinzoni is an academic researcher from University of Paris. The author has contributed to research in topics: Kinase & Protein phosphorylation. The author has an hindex of 23, co-authored 55 publications receiving 1797 citations. Previous affiliations of Marco Bellinzoni include Centre national de la recherche scientifique & Pasteur Institute.

Papers
More filters
Journal ArticleDOI

Mycobacterial Ser/Thr protein kinases and phosphatases: physiological roles and therapeutic potential

TL;DR: The current knowledge on Ser/Thr protein kinases and phosphatases in M. tuberculosis is reviewed, their regulation mechanisms and putative substrates are explored, and their therapeutic potential as possible targets for the development of new anti-mycobacterial compounds are explored.
Journal ArticleDOI

Rv2686c-Rv2687c-Rv2688c, an ABC Fluoroquinolone Efflux Pump in Mycobacterium tuberculosis

TL;DR: The Mycobacterium tuberculosis Rv2686c-Rv2687c-rv2688c operon, encoding an ABC transporter, conferred resistance to ciprofloxacin and, to a lesser extent, norfloxACin, moxifloxacIn, and sparfloxAcin to Myc Cobacterium smegmatis.
Journal ArticleDOI

Regulation of glutamate metabolism by protein kinases in mycobacteria

TL;DR: It is shown that protein kinase G of Mycobacterium tuberculosis undergoes a pattern of autophosphorylation that is distinct from that of other M.’tuberculosis protein kinases characterized to date and GarA is identified as a substrate for phosphorylation by PknG, which may contribute to the attenuation of virulence.
Journal ArticleDOI

The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis.

TL;DR: The inventory of the drug transporters subfamily, included in the major facilitator superfamily (MFS), encoded by the complete genome of Mycobacterium tuberculosis, revealed 16 open reading frames encoding putative drug efflux pumps belonging to MFS, and it is demonstrated that two of them function asDrug efflux proteins.
Journal ArticleDOI

The structure of PknB in complex with mitoxantrone, an ATP-competitive inhibitor, suggests a mode of protein kinase regulation in mycobacteria

TL;DR: It is demonstrated that mitoxantrone, an anthraquinone derivative used in cancer therapy, is a PknB inhibitor capable of preventing mycobacterial growth.